 |
|
Maximum: 1 CME cr.
Sign in to view your progression
|
Topic description:
This learning module summarizes the neural regulation of arousal and genital sensation, and principles in the clinical evaluation and management of persistent genital arousal disorder (PGAD) in women.
Video segments in the learning module:
- Video 1: Sexual Pain in Women: Anatomy & Assessment
- Video 2: Peripheral and Central Mechanisms of Persistent Genital Arousal Disorder
- Video 3: Management of Persistent Genital Arousal Disorder – Peripheral Causes
- Video 4: Management of Persistent Genital Arousal Disorder – Central Causes
Faculty Information
Rachel Rubin, MD
IntimMedicine Specialists
Washington, District of Columbia, USA
James G. Pfaus, PhD
Investigador, Centro de Investigaciones Cerebrales Universidad Veracruzana Xalapa, MEXICO
Professor of Neuroscience & Psychology Concordia University Montreal, Quebec, CANADA
Irwin Goldstein, MD
Director, San Diego Sexual Medicine
Director, Sexual Medicine, Alvarado Hospital
Clinical Professor of Surgery, University of California at San Diego
San Diego, California, USA
Best practice:
Discussion with patients with PGAD should include the various pathophysiologies and strategies for the management of PGAD including pharmacologic and non-pharmacologic treatment options.
Current practice:
Few HCPs have experience with PGAD, and often dismiss the very bothersome complaints with which these women present.
Resulting gaps:
PGAD is a rare but extremely distressing sexual dysfunction that, with appropriate management strategies can often result in improved life quality, but when ignored or unsuccessful can lead to severe emotional distress.
Outcome indicated/Improvement in:
Increasing the number of HCPs willing to manage PGAD will lead improvements in care for women with PGAD.
Learning objectives:
(1) Characterize underlying pathophysiologies leading to PGAD.
(2) Associate therapeutic strategies with specific pathophysiologies of PGAD.
Medical health care practitioners (MDs, DOs, PAs, NPs, etc.) in any field (Sexual Medicine, Obstetrics & Gynecology, Internal Medicine, Family Medicine, Urology, etc.) who would like to address sexual health in caring for their female patients.
ISSWSH Learner Notification
Management of Persistent Genital Arousal Disorder: Anatomy, Diagnosis and Treatment
Dr. R. Rubin, Dr. J. Pfaus and Dr. I. Goldstein
September 01, 2019 - September 01, 2021
Online
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, pass the post-test with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the International Society for the Study of Women’s Sexual Health, Inc. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Objectives - After attending this program you should be able to:
1. Characterize underlying pathophysiologies leading to PGAD.
2. Associate therapeutic strategies with specific pathophysiologies of PGAD.
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
|
First |
Last |
Commercial Interest |
|
I. |
Goldstein |
Coloplast: Consultant, AbbVie: Research Grant Site Principal Investigator, AMAG: Speakers Bureau, AMAG: Research Grant Overall Principal Investigator, Duchesnay: Consultant, Strategic Science & Technologies: Consultant |
|
J. |
Pfaus |
AMAG Pharmaceuticals: Scientific/Medical Advisory Board Member, Emotional Brain LLB: Scientific/Medical Advisory Board Member, IVIX Ltd: Scientific/Medical Advisory Board Member, Palatin Technologies: Research Grant Site Principal Investigator |
|
R. |
Rubin |
IPSEN: Research Grant Site Principal Investigator |
|
Management of Persistent Genital Arousal Disorder: Anatomy, Diagnosis and Treatment
|
|
|
Self-assessment & Certificate
|
|